Member Info for Porky9

@PatientInvestor

Iceman, I think you should apply for a job next to Holly on This Morning, Your heart felt explanation of what shareholders are currently feeling really brought a lump to my throat. Can someone pass me a tissue please to dab my eyes

@Jinky58

Also, the key part of the Update:-

“Whilst the in vivo study did not achieve the desired level of anti-cancer activity, it demonstrated no adverse toxicity leading to the conclusion that further research around this molecular series would be beneficial.”

So in short, it doesn’t work as a cancer cure But the University is at least supported for the next four year block to continue R&D on associated peptides, so at least that’s a positive.

We can’t expect every peptide to work but rather than smoke and mirrors Shareholders just want regular updates on specific progress. I would have more respect for the board if they were straight with us and gave us an honest précis of all of the pipeline.

I fear the reason they won’t is because there is more commercial value just extending, or leaving something on the back burner and not updating on it than marking it as non productive and looking for a new replacement.

Anyhow, it’s 6 days and as OB posted last night, I need to shut up, I totally get it, I’m just personally disappointed at seeing a business that could be potentially great being wasted in the hands of what I see as an incompetent board.

P Poor Directors don’t become good ones overnight they need replacing IMO. Anyhow, see what’s in the bag of tricks to discuss at the presentation.

@OB

Fully noted

Take Care

Pork's

@OB

Its a fair point OB, only six days until we know what Suzy has to say

then decisions can be made good luck,'

Great then 20% dilution will be better than 40%

BUT would be better to do it all in one go for the right amounts in the first place frankly but each to own.

6 trading days and we know for certain.

Meanwhile, amazing how you have done a total 180 from, say no to issue of headline shares scrap resolution 4 to now its only 20m headline shares so that's OK.

Brilliant

@TheWallcrawler

So if you are “inside” and know for sure it’s a 20m headroom request then that in itself is a poor show, if you are not “inside” then it’s pure guesswork.

One thing that is certain is that 20m is nowhere near enough. Just puts VAL in the position of repeating same within another 6 months.

See what happens

Oh come off it, really......

Are you REALLY telling me you are buying this utter BS ??

So after two years, this two bit start up THX that cant get funded for love nor money, is going to be reversed into some offshore asset that's unlisted to be acquired by a NASDAQ listed business headed by some guy called Murphy Canyon and then he's going to delist the offshore company and vola, THX has loads of money to spend on trials.

Utter Utter tripe, oh come on now.....

Let me see some kind of prospectus please, still if you get a spike on the SP from this story good luck to you. no doubt be some dumb enough to believe it, rampers need a spike before Suzy presentation so going full leather to support it but i have never heard anything so ridiculous.

@Iceman

What a pile of utter tosh

Keep ramping in your echo chamber, rest of the market has busted this

15 placings in as many years, no revenue EVER, three 125:1 consolidations and five placings under Suzy and 6th shortly. Market done with JAM, results only that count now.

It is actually YOU that refuses to consider other possibilities. From a commercial perspective THX should have been cut a year ago when they didn't meet the first set of extended deadlines and when they didn't come through with the lab fees. End Of.

Headroom request next week then placement issue early July - watch this space, commercially its the right thing to do based on the current cash runway position which you will try and spin as somehow being longer than 7 months from H2 anyhow

The ramping in this forum and recs on any positive message is ridiculous, this is not a forum to evaluate, its borderline a cult.

Enjoy your day..

@Uncanny

In which case if you think that, you will realise that I fully recognise a P&D attempt when I see one.

It would not surprise me if the brokers are currently testing the waters to establish placement support levels, hence this activity. Pump for best price, dump or short then pick up placing shares to cover?

It’s a Rince repeat process only this time, market conditions are tough, investors not so gullible and we have all seen and worn the t-shirt

Could be completely wrong, will know more once we know the headline share request numbers at Suzy’s presentation.

Come on Nick where are you?

The ramping club are all in place. Time to get started

Rinse repeat

@HarryCaul

It is a Cult in this forum, rampers only, absolutely ridiculous

Cash burn has increased by £800k to the previous year end and that was before the addition of 4 more staff at the start of this FY, kitting out a lab and all the associated costs. Admin costs to go up further this year by 27%, they are on a continued spending spree like Santa before Christmas, and all this at a time when the rest of the sector are battening down the hatches and reducing costs due to the biotech funding drought - you couldn’t make it up.

And the ramping club are heading the thread, brilliant news, well done yet in reality cash burn higher than ever and increasing, still zero delivery and a presentation next week where the request for headroom shares will be an absolute certainty.

Amazing

Good to have the financial position to the end of December finally confirmed, i wouldn't expect too much impact, obviously all eyes will be on the presentation next week that is the main event when they discuss forward plans and if Buy and Build remains, the amount of headroom shares they need, any acquisitions if planned and the forward position from the H2 that will be what affects this apart from a few expected pump and dump players expected to turn up today unless the cash burn is worse than forecast.

The headline figures we are expecting to the year end Dec 22 (so already 6 mths out of date) are:-

AT 31 Dec 2022:-

REVENUE £ 0 (2022) £ 0 (2021)

EBITDA -£ 1,471,000 (2022) -£ 1,264,000 (2021)

PBT -£ 2,313,000 (2022) -£ 1,681,000 (2021)

Net Cash £ 1,386,000 (2022) £ 594,000 (2021)

The thing here is that extra Jan raise after the year end only gave them £1.3m gross, not sure what the costs were. Additional cash burn AFTER the year end Lab fixtures were est £350k, other Lab costs £250k they have three extra staff, 11 now v 9 that will come out of that.

Admin costs forecast to increase in this 23 year by 27% from £1,230,000 to £ 1,518,000 in this year,

I think what i'm most surprised about with this business is that when Kevin came on board April 21 he was really proud of the fact that he had got costs under control following the restructure. (Gerry still remained) but he had capital raise and had significantly slashed costs and the following year Suzy continued that ethos working to keep costs to an absolute minimum.

Now we find that the cost base is back up again to where it was pre crash. I just cant see the logic in this, its like business as usual. Guess its just been too easy to get cash during the biotech funding boom. Now its a different landscape.

Anyhow, presentation on the 14th will be critical here IMO how the market views this, meanwhile lets hope actual cash burn reported today at least not worse than the CENKOS report estimates.

Good Luck

@Minnissage

Wow that’s an old article 18mths old

But as stated it is a different Company.

It obviously doesnt help that two years on there is still no website, prospectus or any published details we can find about what may or may not be trying to raise, very limited info on Ken also. But, Suzy has the details as we understand it.

@IronMighty

Buy and Build is in play - they have NOT said otherwise

IF they propose an acquisition at the presentation such as acquiring PYC, hear them out. If it’s good for the business and long term growth it could be a good thing.

Don’t just discount something out without evaluating if it’s beneficial or not.

They previously suggested 30m headroom. They probably should have 50m headroom. As I keep saying it’s a funding drought for biotechs out there, SH should get behind them and give them the flexibility they need. What’s more important are the forward plans, what they will do over the next year with the investment is what’s important

We will know soon enough, nit long now until the presentation, good luck

@PM2022

Well was your telegram group of 40 all happy clappy buying VAL whilst Nick was offloading his 6% interest in the business?

Was he telling you all what a great investment potential you have whilst selling.

Look @PM2022 you sound like a nice enough guy, but just be careful. Penny shares are high risk, you don’t always know the full picture, as I said before half the time what they don’t say is more important than what they do say.

Take care, leave you with your echo chamber.

@Metom

There is NO risk of this play going bust as long as SH allow headroom shares. That gives the business the flexibility to raise more cash as and when required.

The company can then raise as much as they need at ANY price they can secure support at

It doesn’t matter if they raise at 7p/ 5p/ 3.5p again or even 1p it just means a higher number of shares in issue, and that can be fixed with a consolidation event anyhow.

Nobody is talking about going Bust, that’s not a factor.

@Goomer

It is all about entry point but whilst you have been here moaning and waiting for the dilution event, I have been in and out on HELD for practically a three bag and still have some free shares.

Investments have to work for you. Sometimes you have to consider not just your potential ROI in specific Penny share plays but also lost opportunity elsewhere if you cash is stuck in something drifting, it’s all relevant

@PM2022

Oh your post really did make me chuckle, you genuinely believe it, is it to convince yourself?

Let me illustrate:-

1. You say Headroom shares are required but doesn’t mean they will use them.

REPLY: You are having a laugh. Giving VAL headroom shares and expecting they won’t use them is akin to Asking a Donkey to mind Strawberries.

15 Share issues, Three 125:1 Consolidations and 5 placings under Suzy with 6th to land

2. Everyone here knows we are massively undervalued due to the delays with 201 and the Buy and Build Policy

REPLY: Yes in this echo chamber of a forum you all keep telling yourselves that. From an analytical perspective, it’s massively overvalued due to the multiple issues but moreover, we are now in a biotech funding drought, the SP is doing incredibly well for some holders.

3. And it doesn’t even factor in CLX which is worth at least 20p

REPLY: No it’s not, it’s not worth £20m at this point. They need VAL to find a partner to fund phase trials to see if it works in this current climate. When they do it’s likely to be a milestone based deal with zero or minimal upfront due to how expensive these trials now are. It will take a lot of time. But cash in now short term is unlikely. 201 our Crown Jewels was given to a start up in the expectation of £1.3m down and that after two years still can’t complete. Market conditions for funding currently remain dire.

4. Cash until late 2024 and lots of news due

REPLY: Now you really are stretching it, 7 months cash runway from this H2 is the position. hence why they will ask anytime soon for headway shares. No event can bring cash in short term hence essential SH back the request. As for news, it’s going to take time, they can only update when they have something to say

Frankly your ramping gets worse by the day

@Goomer

I just have to ask you the question:-

A) Do you not think your straw poll is kind of pointless as it will just get lots of likes from holders dreaming of someone else buying rather than them?

B) why would acquiring an asset be a bad thing? If it adds value to the business and better positions VAL for the future surely it’s a positive?

C) You and a number of posting claim the SP is low when in fact it’s NOT. I would argue that VAL even with the issues have still taken the SP from 3.5p August 21 to 9p today. That’s almost a three fold increase. Some investors here have had brilliant returns its all about what entry point you came in at

Pointless poll if you ask me

Contrary to comments here I am NOT interested in driving the share price down, it is for the business to deliver value that ultimately increases the Share Price.

There are many things to fix here, not least 201 but it’s a long-term investment and will need further additional share issues to make that happen.

This obsession with me is bloody ridiculous. As a small shareholder I’m entitled to comment here. The fact that I won’t support the pro ramping agenda here is what some of you object to. A number of my posts have been on point and referenced yet the ramping club request removal or ridicule because it doesn’t fit with what you want to see.

There are a select set of rampers here led by PM2022 hell bent on posting continuous unsubstantiated BS about what is or isn’t happening. That is totally misleading.

I suggest anyone considering this as a possible investment await the presentation from Suzy shortly. Then you will know for sure if Buy and Build is dumped, if headway shares are requested for a placing and the future requirements of the business.

Until then practically every ramping post here you take with a pinch of salt specifically PM2022 and Iceman AKA PatientInvestor.

Enjoy your echo chamber….

Pork's